The Effect of Reducing Total Volume of Sprint Exercise on Circulating Levels of BDNF

Sponsor
University of Stirling (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06069427
Collaborator
(none)
15
1
15
1

Study Details

Study Description

Brief Summary

Regular exercise is well known to be required for good physical health, but exercise can also improve mental health. Although the effects of exercise on mental health have been shown in many studies, it remains unclear how exercise improves mental health. In recent years, the potential role of a specific protein called 'brain-derived neurotrophic factor' (BDNF) has received increasing attention. Higher levels of BDNF in the blood are associated with better cognitive performance, attention, and spatial memory. Conversely, low levels of BDNF in the blood are found in patients with depression, dementia, mild cognitive impairment, and Alzheimer's disease. BDNF can be released during exercise, with greater increases after exercise performed at higher intensities. For example, classic sprint interval training (SIT), which involves four 30-second 'all-out' cycle sprints, has been shown to lead to greater increases in BDNF compared to moderate or vigorous exercise. Although these results suggest that SIT is an effective way to increase BDNF, SIT is not generally considered feasible for patients or untrained members of the general public, because it is a very tiring type of exercise. However, other more manageable protocols have been developed, such as the 'reduced-exertion, high-intensity interval training' (REHIT) protocol, which involves two 20-second 'all-out' sprints within a 10-minute low-intensity exercise session. Although it is clear that BDNF levels increase in an intensity-dependent manner in response to exercise, the effect of exercise volume remains unknown. Exercise intensity is identical for SIT and REHIT, but if BDNF levels increase to a similar extent in response to both protocols, REHIT would constitute a more feasible intervention for use in patients and the general public. The aim of the present study is to compare the effects of REHIT vs. classic SIT on levels of BDNF in the blood. For this,15 study participants will be recruited, who will each complete a SIT session, a REHIT session, and a no-exercise control session. Levels of BDNF will be measured in blood samples taken at rest, as well as directly after exercise, 30 minutes after exercise, and 90 minutes after exercise. It will be determined whether the greater amount of sprint exercise in a SIT session will be associated with a greater increase in levels of BDNF in the blood compared to the REHIT session which consists of a lower amount of sprint exercise.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sprint interval training (SIT)
  • Behavioral: Reduced-exertion high-intensity interval training (REHIT
  • Behavioral: No-exercise control (CON)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Participants will each undergo 3 trials in a randomised order.Participants will each undergo 3 trials in a randomised order.
Masking:
None (Open Label)
Masking Description:
Due to the nature of the interventions (exercise), masking is not possible.
Primary Purpose:
Prevention
Official Title:
The Effect of Reducing Total Volume of Sprint Exercise in Sprint Interval Training Protocols on Circulating Levels of Brain-derived Neurotrophic Factor (BDNF)
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Nov 30, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Outcome Measures

Primary Outcome Measures

  1. Area under the plasma concentration versus time curve (AUC) of BDNF [Pre-exercise, directly post-exercise, and 30 and 90 minutes post-exercise]

    Plasma levels of the protein brain-derived neurotrophic factor (BDNF) will be measured pre-exercise, directly post-exercise, and 30 and 90 minutes post-exercise. The area-under-the-curve for plasma BDNF will be calculated. Differences in AUC between the 3 trails will be determined.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Apparently health young male volunteers
Exclusion Criteria:
  • Age <18 y or >40 y

  • BMI > 35 kg/m2

  • participation in a structured exercise training programme at any time in the preceding 6 months

  • suffering from acute (e.g., common cold, Covid-19, flu, etc) or chronic disease (e.g., diabetes, heart disease, cancer, etc)

  • answering 'yes' to one or more questions of a standard physical activity readiness questionnaire (PAR-Q)

  • resting heart rate ≥100 bpm

  • clinically significant hypertension (>140/90 mm Hg)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Stirling Stirling Midlothian United Kingdom FK9 4LA

Sponsors and Collaborators

  • University of Stirling

Investigators

  • Principal Investigator: Niels Vollaard, PhD, University of Stirling

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Niels Vollaard, Lecturer, University of Stirling
ClinicalTrials.gov Identifier:
NCT06069427
Other Study ID Numbers:
  • 14395
First Posted:
Oct 5, 2023
Last Update Posted:
Oct 5, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 5, 2023